Serial Retinal Thickness Changes And Scotoma Size Measured With Lucentis Therapy

NCT01255774 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Age Related Macular Degeneration

Interventions

DRUG: ranibizumab

Sponsor

The New York Eye & Ear Infirmary

Collaborators

[object Object]